Bronchiolitis - Treatments

Author

In this section

 

Most babies or young children with bronchiolitis can be cared for at home. But you should get medical help if your child doesn't drink and starts to get dehydrated (become too low in body fluids) or has difficulty breathing.

Bronchiolitis is an infection of the small tubes (bronchioles) inside the lungs.

The symptoms of bronchiolitis aren't severe for most young children. But the illness can become serious for babies and infants who have other lung diseases or heart diseases. Babies who are born prematurely or who have problems fighting off infections (have an immune problem) may also be at greater risk from life-threatening bronchiolitis.[1]

  • Your baby may need care in hospital until he or she is over the illness.
  • Your baby may need to be fed through a special tube into their stomach and given extra oxygen.
  • Treatment with medicines is unlikely to help your child recover from bronchiolitis.
  • A course of injections of palivizumab (brand name Synagis) each month during the winter can protect babies at high risk of life-threatening bronchiolitis.

We've looked closely at the research and ranked the treatments into categories, according to whether they work.

Treatments that work

Palivizumab injections to prevent bronchiolitis

If your baby is at high risk of life-threatening bronchiolitis, injections of a medicine called palivizumab (brand name Synagis) each month during the winter might mean they don't have to go to hospital.

Doctors only use these medicines to prevent bronchiolitis. They aren't used to treat babies and children who already have the illness.

Palivizumab is an antibody that can protect your baby against respiratory syncytial virus (RSV), the main cause of bronchiolitis. Your body naturally produces antibodies to defend it against viruses or bacteria. But if your baby has serious heart problems or lung problems, they might need the extra protection of antibody injections.

Doctors used to give babies another medicine called an immunoglobulin (brand name RespiGam). This medicine also fights the respiratory syncytial virus (RSV). But this drug has to be fed into a vein by a drip for four hours. Palivizumab is a newer drug and much easier to give to your baby. Your baby needs only one injection of palivizumab a month into the muscle of their thigh. Doctors usually prescribe palivizumab to babies at a high risk of getting bronchiolitis.

Usually, children will only have this sort of treatment if they:[2]

  • Were born prematurely (before 35 weeks)
  • Are under 2 years of age and have a serious lung disease, which means they need extra oxygen
  • Are under 2 years of age and have a serious heart disease.

There is plenty of research to show this medicine works. We found five good-quality studies (randomised controlled trials) including nearly 5,000 children with serious lung disease or heart disease. Children at high risk from bronchiolitis were half as likely to have to go to hospital if they had palivizumab or immunoglobulin through a drip.[3] [4]

This treatment has side effects but they aren't common. There's a small chance that your baby will get a fever or a skin reaction where they are injected with palivizumab.[4] One study also found that babies who were given this drug were slightly more likely to get serious breathing difficulties.

About 3 in 100 children who were put on an immunoglobulin drip had complications. They breathed faster, had a fever, a skin reaction where they were injected, and a slight decrease in oxygen in their blood.[3] The immunoglobulin shouldn't be given to babies with serious heart disease.[2]

Treatments that are likely to work

Taking care to prevent bronchiolitis from spreading

If nurses and doctors wash their hands between patients this helps a lot to prevent infection, including bronchiolitis, spreading to other children.[5] Separating babies with bronchiolitis from children who don't have it may also help, as may getting nurses and other hospital staff to wear gowns, masks and gloves.[6]

But more research into different nursing practices is needed to be sure of the best way of preventing the spread of bronchiolitis to other babies and young children in hospital.

Treatments that need further study

Bronchodilators

Bronchodilators are drugs that are used to make your airways (bronchioles) open up (dilate). They are normally used to quickly help people with asthma. Examples include salbutamol (Ventolin, Airomir), orciprenaline (Alupent), adrenaline, ipratropium bromide (Atrovent) and aminophylline.

Sometimes babies are given this drug if they have problems breathing because of bronchiolitis. They are usually breathed in (inhaled), although they can also be given as injections.

We found quite a few studies (called randomised controlled trials) of these medicines for bronchiolitis. These found that, for children with mild to moderate symptoms, bronchodilators might help with breathing. But they won't help children who have more severe bronchiolitis and need to be treated in hospital.[7] [8] [9] [10] For example, there's no evidence that bronchodilators can prevent your child having to go into hospital or reduce the time they need to spend in hospital. More good research is needed to know for certain whether or not these drugs help with bronchioloitis.

There's a risk of side effects from bronchodilators. A child who takes them may get a fast heartbeat, increased blood pressure, less oxygen in their blood, flushing, hyperactivity, cough and tremor (muscle movements that can't be controlled) after using a bronchodilator.[7]

Physiotherapy

A physiotherapist may sometimes work with a child to try to remove the phlegm from their lungs. The idea is that this will help them breathe more easily. Physiotherapists can do this in various ways. For example, they may put your child in a position that helps their lungs drain. Or they might pat your child's chest to help the fluids move from their lungs into their throat. But there's no evidence from the three studies we found that chest physiotherapy helps children with bronchiolitis who are treated in hospital go home sooner.[11] More research is needed to know whether or not this treatment works.

There's no evidence from these studies that chest physiotherapy is harmful.

Montelukast

Montelukast (brand name Singulair) is a drug that's sometimes used to treat asthma. It's used to help calm down the airways to prevent children getting asthma symptoms. We haven't found any good studies to show whether or not this treatment works for children with bronchiolitis.

Ribavirin

Ribavirin (brand name Virazole) is a medicine that attacks viruses. It isn't usually given to babies with bronchiolitis. There's no clear evidence that this drug will help your baby get better.

One summary of the research (called a systematic review) found that children given ribavirin were just as likely to get worse, die or need to stay in hospital as children given a dummy treatment (a placebo).[12] But there is some evidence that ribavirin may reduce the length of time a child needs to stay on a ventilating machine to help with breathing.[12]

Treatment with ribavirin probably won't help in the long term either. Two studies (randomised controlled trials) found that children treated with ribavirin for bronchiolitis were just as likely to have a wheezing illness and need hospital treatment the following year as those who had a dummy treatment (a placebo).[13] [14]

Ribavirin can have side effects. The lungs of some children go into a spasm after treatment. People looking after children who are taking ribavirin can get headaches and problems with contact lenses.[15]

Surfactants

Surfactants are drugs that are usually used to help premature babies breathe more easily. They are similar to the natural fluid in your lungs. They are put into your lungs through a tube in your windpipe. Beractant (brand name Survanta) and poractant (Curosurf) are two products available in the UK.

Some small studies have looked at surfactants in children with bronchiolitis who have to go on a ventilator. The studies found that the children needed to spend less time in the hospital intensive care units of their hospitalsl.[16] But we need more studies to know whether or not this treatment works.

The studies we found did not report any problems with this treatment. But, in premature babies, surfactants can sometimes create more mucus in the lungs, which can make breathing more difficult. They can also make the lungs bleed. But this is very rare.

Treatments that are unlikely to work

Steroids

Steroids are medicines that reduce inflammation. They are often used to help control asthma. Doctors are unlikely to give steroids to a baby with bronchiolitis.

Lots of studies have found that steroids are unlikely to help children who have bronchiolitis avoid going into hospital or make their stay in hospital any shorter.[17] [18] [19]

Steroids have side effects. Sometimes, blood sugar levels get too high. This is called hyperglycaemia. And the drugs can affect a child's immune system and make them less able to fight infections.[20] A few children in the studies got muscle movements (tremors) after breathing in steroids.[21]

References

  1. Purcell K, Fergie J Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. The Pediatric Infectious Disease Journal. 2004; 23: 418-423.
  2. American Academy of Pediatrics. Revised indications for the use of palivizumab and RSV immune globulin intravenously for the prevention of RSV infection. Pediatrics. 2003; 112: 1442-1446. Also available at http://aappolicy.aappublications.org (accessed on 12 November 2007).
  3. Wang EEL, Tang NK. Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane review). In: The Cochrane Library, Issue 3, 2006. Wiley, Chichester, UK.
  4. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital hearth disease. Journal of Pediatrics. 2003; 143: 532-540.
  5. Isaacs D, Dickson H, O'Callagham C, et al. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Archives of Disease in Childhood. 1991; 66: 227-231.
  6. Madge P, Patron JY, McColl JH, et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet. 1992; 340: 1079-1083.
  7. Gadomski AM, Bhasale AL. Bronchdilators for bronciolitis. In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  8. Hartling L, Wiebe N, Russell K, et al. Epinephrine for bronchiolitis. In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  9. Ralston S, Hartenberger C, Anaya T, et al. Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. Pediatric Pulmonology. 2005; 40: 292-299.
  10. Langley M, LeBlanc JC, Wang EEL, et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals. Pediatrics. 1997; 100: 943-946.
  11. Perrotta C, Ortiz Z, Roque M, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old (Cochrane review). In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  12. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Cochrane review). In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  13. Everard ML, Swarbrick A, Rigby AS, et al. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respiratory Medicine. 2001; 95: 275-280.
  14. Edell D, Khoshoo V, Ross G, et al. Early ribavirin treatment of bronchiolitis: effect on long-term respiratory morbidity. Chest. 2002; 122: 935-939.
  15. Edelson PJ. Reactions to ribavirin. Pediatric Infectious Disease Journal. 1991; 10: 82.
  16. Ventre K, Haroon M, Davison C, et al. Surfactant therapy for bronchiolitis in critically ill infants (Cochrane review). In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  17. Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children (Cochrane review). In: The Cochrane Library, Issue 4, 2004. Wiley, Chichester, UK.
  18. Davidson C, Ventre KM, Luchetti M, et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatric Critical Care Medicine. 2004; 5: 482-489.
  19. King VJ, Viswanathan M, Bordley C, et al. Pharmacologic treatment of bronchiolitis in infants and children (Cochrane review). In: The Cochrane Library, Issue 4, 2006. Wiley, Chichester, UK.
  20. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE (editors). Goodman and Gilman's the pharmacological basis of therapeutics. 10th edition. McGraw-Hill, New York, U.S.A.; 2001.
  21. Patel H, Platt R, Lozano JM, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children (Cochrane review). In: The Cochrane Library, Issue 4, 2004. Wiley, Chichester, UK.

Glossary

asthma
Asthma is a disease of the lungs. It makes you wheeze, cough and feel short of breath. Asthma attacks are caused by inflammation and narrowing of your airways, which makes it hard for air to pass in and out of your lungs.
antibodies
Antibodies are an important part of your immune system. They are proteins made by white blood cells (another part of your immune system). They help destroy bacteria and other agents that cause infections.
randomised controlled trials
Randomised controlled trials are medical studies designed to test whether a treatment works. Patients are split into groups. One group is given the treatment being tested (for example, an antidepressant drug) while another group (called the comparison or control group) is given an alternative treatment. This could be a different type of drug or a dummy treatment (a placebo). Researchers then compare the effects of the different treatments.
systematic reviews
A systematic review is a thorough look through published research on a particular topic. Only studies that have been carried out to a high standard are included. A systematic review may or may not include a meta-analysis, which is when the results from individual studies are put together.
placebo
A placebo is a 'pretend' or dummy treatment that contains no active substances. A placebo is often given to half the people taking part in medical research trials, for comparison with the 'real' treatment. It is made to look and taste identical to the drug treatment being tested, so that people in the studies do not know if they are getting the placebo or the 'real' treatment. Researchers often talk about the 'placebo effect'. This is where patients feel better after having a placebo treatment because they expect to feel better. Tests may indicate that they actually are better. In the same way, people can also get side effects after having a placebo treatment. Drug treatments can also have a 'placebo effect'. This is why, to get a true picture of how well a drug works, it is important to compare it against a placebo treatment.

© BMJ Publishing Group Limited ("BMJ Group") 2007. All rights reserved

This information does not replace medical advice. If you are concerned you might have a medical problem please ask your Boots pharmacy team in your local Boots store, or see your doctor.

Boots

Prescriptions Basket

Prescriptions Basket

My Account

Sign In or Register